158 related articles for article (PubMed ID: 23537502)
21. Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression.
Mendlewicz J; Crisafulli C; Calati R; Kocabas NA; Massat I; Linotte S; Kasper S; Fink M; Sidoti A; Scantamburlo G; Ansseau M; Antonijevic I; Forray C; Snyder L; Bollen J; Montgomery S; Zohar J; Souery D; Serretti A
Neurosci Lett; 2012 May; 516(1):85-8. PubMed ID: 22487732
[TBL] [Abstract][Full Text] [Related]
22. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
Breitenstein B; Scheuer S; Pfister H; Uhr M; Lucae S; Holsboer F; Ising M; Brückl TM
CNS Spectr; 2014 Apr; 19(2):165-75. PubMed ID: 23880209
[TBL] [Abstract][Full Text] [Related]
23. Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility.
Li M; Luo XJ; Rietschel M; Lewis CM; Mattheisen M; Müller-Myhsok B; Jamain S; Leboyer M; Landén M; Thompson PM; Cichon S; Nöthen MM; Schulze TG; Sullivan PF; Bergen SE; Donohoe G; Morris DW; Hargreaves A; Gill M; Corvin A; Hultman C; Toga AW; Shi L; Lin Q; Shi H; Gan L; Meyer-Lindenberg A; Czamara D; Henry C; Etain B; Bis JC; Ikram MA; Fornage M; Debette S; Launer LJ; Seshadri S; Erk S; Walter H; Heinz A; Bellivier F; Stein JL; Medland SE; Arias Vasquez A; Hibar DP; Franke B; Martin NG; Wright MJ; ; ; ; ; ; Su B
Mol Psychiatry; 2014 Apr; 19(4):452-61. PubMed ID: 23568192
[TBL] [Abstract][Full Text] [Related]
24. Preliminary investigation of the influence of CREB1 gene polymorphisms on cognitive dysfunction in Chinese patients with major depression.
Guo J; Liu Z; Dai H; Zhu Z; Wang H; Yang C; Xiao L; Huang Y; Wang G
Int J Neurosci; 2014 Jan; 124(1):22-9. PubMed ID: 23844928
[TBL] [Abstract][Full Text] [Related]
25. The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.
Kautzky A; Baldinger P; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
Eur Neuropsychopharmacol; 2015 Apr; 25(4):441-53. PubMed ID: 25769916
[TBL] [Abstract][Full Text] [Related]
26. The Impact of
Santos M; Lima L; Carvalho S; Mota-Pereira J; Pimentel P; Maia D; Correia D; Barroso MF; Gomes S; Cruz A; Medeiros R
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047730
[TBL] [Abstract][Full Text] [Related]
27. The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders.
Xiao X; Zhang C; Grigoroiu-Serbanescu M; Wang L; Li L; Zhou D; Yuan TF; Wang C; Chang H; Wu Y; Li Y; Wu DD; Yao YG; Li M
Mol Psychiatry; 2018 Sep; 23(9):1957-1967. PubMed ID: 29158582
[TBL] [Abstract][Full Text] [Related]
28. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
[TBL] [Abstract][Full Text] [Related]
29. Association study of p11 gene with major depressive disorder, suicidal behaviors and treatment response.
Tzang RF; Hong CJ; Liou YJ; Yu YW; Chen TJ; Tsai SJ
Neurosci Lett; 2008 Dec; 447(1):92-5. PubMed ID: 18838110
[TBL] [Abstract][Full Text] [Related]
30. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
Serretti A; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Pae CU
Psychiatry Res; 2011 Aug; 189(1):26-32. PubMed ID: 21396719
[TBL] [Abstract][Full Text] [Related]
31. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
[TBL] [Abstract][Full Text] [Related]
32. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
[TBL] [Abstract][Full Text] [Related]
33. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression.
Murphy GM; Sarginson JE; Ryan HS; O'Hara R; Schatzberg AF; Lazzeroni LC
Pharmacogenet Genomics; 2013 Jun; 23(6):301-13. PubMed ID: 23619509
[TBL] [Abstract][Full Text] [Related]
34. Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
Pae CU; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Serretti A; De Ronchi D
Neuropsychobiology; 2012; 65(1):1-11. PubMed ID: 22094229
[TBL] [Abstract][Full Text] [Related]
35. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
[TBL] [Abstract][Full Text] [Related]
36. Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia.
Crisafulli C; Chiesa A; Han C; Lee SJ; Shim DS; Balzarro B; Andrisano C; Sidoti A; Patkar AA; Pae CU; Serretti A
Neurosci Lett; 2012 Feb; 508(1):37-41. PubMed ID: 22198373
[TBL] [Abstract][Full Text] [Related]
37. CREB1 gene polymorphisms combined with environmental risk factors increase susceptibility to major depressive disorder (MDD).
Wang P; Yang Y; Yang X; Qiu X; Qiao Z; Wang L; Zhu X; Sui H; Ma J
Int J Clin Exp Pathol; 2015; 8(1):906-13. PubMed ID: 25755794
[TBL] [Abstract][Full Text] [Related]
38. HTR2A gene variation is involved in antidepressant treatment response.
Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
[TBL] [Abstract][Full Text] [Related]
39. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.
Fabbri C; Corponi F; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():203-210. PubMed ID: 28989100
[TBL] [Abstract][Full Text] [Related]
40. The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study.
Altamura AC; Mundo E; Cattaneo E; Pozzoli S; Dell'osso B; Gennarelli M; Vergani C; Trabattoni D; Arosio B; Clerici M
Neuroimmunomodulation; 2010; 17(2):126-31. PubMed ID: 19923858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
